丽珠医药集团股份有限公司（01513）8月27日公告称，公司董事会已决定于2026年9月8日（星期二）召开董事会会议，拟审议并批准有关派发特别股息的议案。
公告指出，如董事会在届时通过该项建议，公司将于会后另行披露特别股息的具体安排与金额。
公司提醒投资者，鉴于特别股息提议尚待董事会审议并可能获批或未获批，股东及潜在投资者在买卖公司证券时应保持审慎。
截至公告披露日，公司董事会成员包括：执行董事刘大平（总裁）、唐阳刚（副董事长）；非执行董事朱保国（董事长）、林楠棋、邱庆丰；职工董事冉永梅；独立非执行董事罗会远、崔丽婕、王智瑶及康立。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.